New drug trial aims to stop deadly esophageal Cancer's return
NCT ID NCT07266480
Summary
This study is testing if a drug called adebrelizumab can help prevent esophageal cancer from returning after surgery. It will involve 142 adults who have recently had surgery to remove their cancer but have not yet received any other post-surgery treatment. Researchers will compare how long patients stay cancer-free and monitor their quality of life and any side effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SQUAMOUS OESOPHAGEAL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
12, Jiankang road, Chang'an District, Shijiazhuang, Hebei 050000, China
RECRUITINGShijiazhuang, Hebei, China
Contact
Conditions
Explore the condition pages connected to this study.